Kazuyoshi Kumagai

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Toxicologic pathology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Michiko Yamato, Jun Hasegawa, Takanori Maejima, Chiharu Hattori, Kazuyoshi Kumagai, Akiko Watanabe, Yumi Nishiya, Tomoko Shibutani, Tetsuo Aida, Ichiro Hayakawa, Takashi Nakada, Yuki Abe, Toshinori Agatsuma
DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody-Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical Models. Molecular cancer therapeutics 21 (4) (2022)
Kazuyoshi Kumagai, Tetsuo Aida, Yoshimi Tsuchiya, Yuki Kishino, Kiyonori Kai, Kazuhiko Mori
Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2-targeting Ab-drug conjugate, in monkeys. Cancer science 111 (12) (2020)
Kyohei Yasuno, Kazuyoshi Kumagai, Takuma Iguchi, Yoshimi Tsuchiya, Kiyonori Kai, Kazuhiko Mori
DS-7250, a Diacylglycerol Acyltransferase 1 Inhibitor, Enhances Hepatic Steatosis in Zucker Fatty Rats via Upregulation of Fatty Acid Synthesis. Toxicologic pathology 46 (3) (2018)